ECTRIMS 2022

Attending ECTRIMS 2022? Stop by booth C28 to learn about our complete solution for the early detection, diagnosis, and management of multiple sclerosis and other major neurological disorders, including our clinically focused multiple sclerosis report.

Continue ReadingECTRIMS 2022

Earlier diagnosis is essential for better dementia care: conversations at AAIC 2022

For the collective dementia community, an earlier diagnosis leads to more appropriate care and, ultimately, better patient outcomes. Read more about how thought leaders and clinicians at AAIC 2022 suggest we can improve dementia diagnosis in this blog post.

Continue ReadingEarlier diagnosis is essential for better dementia care: conversations at AAIC 2022

Building trust in AI for routine radiology use: what we heard at ECR 2022

The need to demystify AI in radiology applications was one of our key takeaways from ECR 2022. Read about some of the discussions and other themes in this blog post from Peter Ngum, Combinostics Clinical Application Specialist, and Greg Kingston, Combinostics Chief Marketing Officer (CMO).

Continue ReadingBuilding trust in AI for routine radiology use: what we heard at ECR 2022

Combinostics’ cDSI and cMRI Applications, Part of the cNeuro Platform, Receive EC-certification Under the EU’s Medical Device Regulation (MDR)

cNeuro® cDSI™ and cNeuro cMRI™ achieve EC-certification under MDR, ensuring continued delivery of services to European customers.

Continue ReadingCombinostics’ cDSI and cMRI Applications, Part of the cNeuro Platform, Receive EC-certification Under the EU’s Medical Device Regulation (MDR)